{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:45:25Z","timestamp":1790747125107,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/ncpuro0839","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T16:41:46Z","timestamp":1183653706000},"page":"379-386","source":"Crossref","is-referenced-by-count":12,"title":["Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going"],"prefix":"10.1038","volume":"4","author":[{"name":"on behalf of the GKT Botulinum Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sahai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prokar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpuro0839_CR1","first-page":"3027","volume":"13","author":"G Karsenty","year":"2006","unstructured":"Karsenty G  et al. (2006) Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results. Can J Urol 13: 3027\u20133033","journal-title":"Can J Urol"},{"key":"BFncpuro0839_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1464-410X.2006.06184.x","volume":"98","author":"YC Chuang","year":"2006","unstructured":"Chuang YC  et al. (2006) The potential and promise of using botulinum toxin in the prostate gland. BJU Int 98: 28\u201332","journal-title":"BJU Int"},{"key":"BFncpuro0839_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B  et al. (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174: 196\u2013200","journal-title":"J Urol"},{"key":"BFncpuro0839_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"R Popat","year":"2005","unstructured":"Popat R  et al. (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174: 984\u2013989","journal-title":"J Urol"},{"key":"BFncpuro0839_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1464-410X.2006.06086.x","volume":"97","author":"SM Finney","year":"2006","unstructured":"Finney SM  et al. (2006) A double-blind, placebo controlled study investigating efficacy of botulinum toxin type A (Dysport) in MS related overactive bladder syndrome (OAB): Provisional 12-week clinical results [abstract]. BJU Int 97: 31\u201332","journal-title":"BJU Int"},{"issue":"Suppl","key":"BFncpuro0839_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1569-9056(06)61111-1","volume":"5","author":"I Ehren","year":"2006","unstructured":"Ehren I  et al. (2006) Treatment with botulinum toxin A in neurogenic bladder dysfunction\u2014a randomised double-blind study with Dysport [abstract]. Eur Urol 5 (Suppl): 299","journal-title":"Eur Urol"},{"key":"BFncpuro0839_CR7","unstructured":"Sahai A  et al. Efficacy of botulinum toxin-A in treating idiopathic detrusor overactivity: results from a single center, randomised, double blind, placebo controlled trial. J Urol (in press)"},{"key":"BFncpuro0839_CR8","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","volume":"174","author":"M Ghei","year":"2005","unstructured":"Ghei M  et al. (2005) Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 174: 1873\u20131877","journal-title":"J Urol"},{"key":"BFncpuro0839_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","volume":"64","author":"T Odergren","year":"1998","unstructured":"Odergren T  et al. (1998) A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64: 6\u201312","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpuro0839_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"DM Schmid","year":"2006","unstructured":"Schmid DM  et al. (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176: 177\u2013185","journal-title":"J Urol"},{"issue":"Suppl 1","key":"BFncpuro0839_CR11","first-page":"A60","volume":"20","author":"A Sahai","year":"2006","unstructured":"Sahai A  et al. (2006) Urodynamic assessment of poor responders following intra-detrusor injections of botulinum toxin A for overactive bladder [abstract]. J Endourol 20 (Suppl 1): A60","journal-title":"J Endourol"},{"key":"BFncpuro0839_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06192.x","volume":"98","author":"PS Patki","year":"2006","unstructured":"Patki PS  et al. (2006) Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury. BJU Int 98: 77\u201382","journal-title":"BJU Int"},{"key":"BFncpuro0839_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1464-410X.2006.06091.x","volume":"97","author":"A Ruffion","year":"2006","unstructured":"Ruffion A  et al. (2006) What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 97: 1030\u20131034","journal-title":"BJU Int"},{"key":"BFncpuro0839_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.sc.3101318","volume":"40","author":"JJ Wyndaele","year":"2002","unstructured":"Wyndaele JJ and Van Dromme SA (2002) Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40: 599\u2013600","journal-title":"Spinal Cord"},{"key":"BFncpuro0839_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J  et al. (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47: 653\u2013659","journal-title":"Eur Urol"},{"key":"BFncpuro0839_CR16","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E Comperat","year":"2006","unstructured":"Comperat E  et al. (2006) Histologic features in the urinary bladder wall affected from neurogenic overactivity\u2014a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 50: 1058\u20131064","journal-title":"Eur Urol"},{"key":"BFncpuro0839_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","volume":"46","author":"A Haferkamp","year":"2004","unstructured":"Haferkamp A  et al. (2004) Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol 46: 784\u2013791","journal-title":"Eur Urol"},{"key":"BFncpuro0839_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1123654","volume":"312","author":"M Dong","year":"2006","unstructured":"Dong M  et al. (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312: 592\u2013596","journal-title":"Science"},{"key":"BFncpuro0839_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B  et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692\u2013697","journal-title":"J Urol"},{"key":"BFncpuro0839_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/nau.20090","volume":"24","author":"A Sahai","year":"2005","unstructured":"Sahai A  et al. (2005) Botulinum toxin for the treatment of lower urinary tract symptoms: a review. Neurourol Urodyn 24: 2\u201312","journal-title":"Neurourol Urodyn"},{"key":"BFncpuro0839_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A  et al. (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49: 644\u2013650","journal-title":"Eur Urol"},{"key":"BFncpuro0839_CR22","first-page":"37","volume":"77","author":"PJ Smet","year":"1997","unstructured":"Smet PJ  et al. (1997) Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77: 37\u201349","journal-title":"Lab Invest"},{"key":"BFncpuro0839_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","volume":"45","author":"M Khera","year":"2004","unstructured":"Khera M  et al. (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45: 987\u2013993","journal-title":"Neurochem Int"},{"key":"BFncpuro0839_CR24","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","volume":"175","author":"DE Rapp","year":"2006","unstructured":"Rapp DE  et al. (2006) Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol 175: 1138\u20131142","journal-title":"J Urol"},{"key":"BFncpuro0839_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","volume":"172","author":"YC Chuang","year":"2004","unstructured":"Chuang YC  et al. (2004) Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 172: 1529\u20131532","journal-title":"J Urol"},{"key":"BFncpuro0839_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.urology.2004.10.057","volume":"65","author":"H Atiemo","year":"2005","unstructured":"Atiemo H  et al. (2005) Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model. Urology 65: 622\u2013626","journal-title":"Urology"},{"key":"BFncpuro0839_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis A  et al. (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977\u2013982","journal-title":"J Urol"},{"key":"BFncpuro0839_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","volume":"38","author":"MJ Welch","year":"2000","unstructured":"Welch MJ  et al. (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38: 245\u2013258","journal-title":"Toxicon"},{"key":"BFncpuro0839_CR29","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1042\/bst026s108","volume":"26","author":"JR Purkiss","year":"1998","unstructured":"Purkiss JR  et al. (1998) A method for the measurement of [3H]-glutamate release from cultured dorsal root ganglion neurons. Biochem Soc Trans 26: S108","journal-title":"Biochem Soc Trans"},{"key":"BFncpuro0839_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui M  et al. (2004) Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107: 125\u2013133","journal-title":"Pain"},{"key":"BFncpuro0839_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2005","unstructured":"Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26: 785\u2013793","journal-title":"Neurotoxicology"},{"key":"BFncpuro0839_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1212\/WNL.40.2.277","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J and Schwartz K (1990) Botulinum toxin injections for cervical dystonia. Neurology 40: 277\u2013280","journal-title":"Neurology"},{"key":"BFncpuro0839_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1464-410X.2006.06063.x","volume":"97","author":"A Sahai","year":"2006","unstructured":"Sahai A  et al. (2006) Techniques for the intradetrusor administration of botulinum toxin. BJU Int 97: 675\u2013678","journal-title":"BJU Int"},{"key":"BFncpuro0839_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","volume":"92","author":"M Harper","year":"2003","unstructured":"Harper M  et al. (2003) A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 92: 325\u2013326","journal-title":"BJU Int"},{"key":"BFncpuro0839_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1089\/end.2005.19.880","volume":"19","author":"CP Smith","year":"2005","unstructured":"Smith CP and Chancellor MB (2005) Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 19: 880\u2013882","journal-title":"J Endourol"},{"key":"BFncpuro0839_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","volume":"65","author":"CP Smith","year":"2005","unstructured":"Smith CP  et al. (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65: 37\u201341","journal-title":"Urology"},{"key":"BFncpuro0839_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1464-410X.2005.05368_7.x","volume":"95","author":"H Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H and Knispel HH (2005) A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 95: 454","journal-title":"BJU Int"},{"key":"BFncpuro0839_CR38","first-page":"5","volume":"24","author":"G Karsenty","year":"2005","unstructured":"Karsenty G  et al. (2005) Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI)\u2014a prospective randomized study to compare 30 vs 10 injection sites [abstract]. Neurourol Urodyn 24: 5\u20136","journal-title":"Neurourol Urodyn"},{"issue":"Suppl","key":"BFncpuro0839_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1569-9056(06)61109-3","volume":"5","author":"S Boy","year":"2006","unstructured":"Boy S  et al. (2006) Botulinum toxin injections into the bladder wall\u2014a morphological evaluation of the injection technique using magnetic resonance imaging [abstract]. Eur Urol 5 (Suppl): 299","journal-title":"Eur Urol"},{"key":"BFncpuro0839_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.urology.2005.01.055","volume":"66","author":"M Khera","year":"2005","unstructured":"Khera M  et al. (2005) In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology 66: 208\u2013212","journal-title":"Urology"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0839","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpuro0839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:16:31Z","timestamp":1684440991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BFncpuro0839"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0839","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}